The role of the Dopamine D2 receptor TaqIA polymorphism in postoperative nausea and vomiting

The role of the Dopamine D2 receptor TaqIA polymorphism in postoperative nausea and vomiting - TaqPONV

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005681

Enrollment

310

Registered

2014-03-06

Start date

2008-06-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R11

Interventions

Group 1: It is a genetic observational study. For the study participants, blood is removed and the patient be genotyped the DRD2 TaqIA genotypes. There arise from 3 arms with the respective genotypes.

Eligibility

Sex/Gender

All

Age

2 Years to 80 Years

Inclusion criteria

Inclusion criteria: Strabism Operation

Exclusion criteria

Exclusion criteria: neurological or psychiatric disorders

Design outcomes

Primary

Measure	Time frame
Occurrence of PONV (postoperative nausea and vomiting)	—

Secondary

Measure	Time frame
Drug side effects	—

Countries

Germany

Contacts

Public ContactUlrich Frey

UK Essen

ulrich.frey@uk-essen.de02017231401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 4, 2026